176 related articles for article (PubMed ID: 26910279)
1. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue.
Roy J; Putt KS; Coppola D; Leon ME; Khalil FK; Centeno BA; Clark N; Stark VE; Morse DL; Low PS
Oncotarget; 2016 Mar; 7(12):14605-15. PubMed ID: 26910279
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
Wayua C; Low PS
J Nucl Med; 2015 Jan; 56(1):113-9. PubMed ID: 25500824
[TBL] [Abstract][Full Text] [Related]
3. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors.
Sanchez C; Escrieut C; Clerc P; Gigoux V; Waser B; Reubi JC; Fourmy D
Mol Cell Endocrinol; 2012 Feb; 349(2):170-9. PubMed ID: 22040601
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
Rai R; Kim JJ; Tewari M; Shukla HS
J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
[TBL] [Abstract][Full Text] [Related]
8. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
Yu HG; Tong SL; Ding YM; Ding J; Fang XM; Zhang XF; Liu ZJ; Zhou YH; Liu QS; Luo HS; Yu JP
Int J Cancer; 2006 Dec; 119(12):2724-32. PubMed ID: 16998832
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
11. Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan.
Huang BP; Lin CH; Chen YC; Kao SH
Tumour Biol; 2016 Apr; 37(4):4579-84. PubMed ID: 26508021
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target.
Chang J; Liu ZS; Song DF; Li M; Zhang S; Zhao K; Guan YT; Ren HL; Li YS; Zhou Y; Liu XL; Lu SY; Hu P
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2205-2217. PubMed ID: 32488497
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.
Kaloudi A; Nock BA; Krenning EP; Maina T; De Jong M
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):287-302. PubMed ID: 26158215
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung cancer.
Gu J; Chen J; Feng J; Liu Y; Xue Q; Mao G; Gai L; Lu X; Zhang R; Cheng J; Hu Y; Shao M; Shen H; Huang J
Tumour Biol; 2016 Jul; 37(7):8681-9. PubMed ID: 26738863
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues.
Sellam F; Harir N; Khaled MB; Mrabent NM; Belkralladi H; Tou A; Diaf M; Salah R; Moulessehoul S
Pancreatology; 2015; 15(6):661-6. PubMed ID: 26520651
[TBL] [Abstract][Full Text] [Related]
18. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
[TBL] [Abstract][Full Text] [Related]
19. Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells.
Yu HG; Schäfer H; Mergler S; Müerköster S; Cramer T; Höcker M; Herzig KH; Schmidt WE; Schmitz F
Cell Signal; 2005 Dec; 17(12):1505-15. PubMed ID: 15951156
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancer.
Wayua C; Low PS
Mol Pharm; 2014 Feb; 11(2):468-76. PubMed ID: 24325469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
